Abstract
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease in infants and young children. Most infections due to RSV are mild and do not require hospitalization. RSV causes both upper respiratory tract infections as well as lower respiratory tract infections. Infants with underlying disease states like bronchopulmonary dyslasia, congenital heart disease and prematurity appear more prone to develop severe infection and have a higher incidence of hospitalization. The exact pathogenesis of RSV is not well understood. The mortality associated with primary RSV infection in healthy children is estimated to be between .005% to .02%. In hospitalized children the mortality rate is estimated to be from 1% to 3%. Several treatment modalities in the form of bronchodilators, corticosteroids, ribavirin, intravenous immune gammaglobulin and antibiotics are available. Studies have failed to show the true beneficial effect of any of the above treatment modalities. Supportive care is only needed. The best treatment is the supportive care in the form of oxygen and fluids and close monitoring of the vital signs including oxygen saturation.
Article PDF
Similar content being viewed by others
References
Ruuskanen O, Ogra PL. Respiratory syncytial virus.Curr Probl Pediatr 1993; 23 (2): 50–79.
State of Art; Pediatric Intensive Care. In: Brunow de Carvalho W, ed.5th Brazilian Congress of Pediatric Intensive Care.
Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, eds.Textbook of pediatric infections diseases. 2nd ed. Philadelphia: WB Saunders, 1987; 1653–1679.
Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.Pediatrics 1988; 82: 199–203.
Meert K, Heidemann S, Abella B,et al. Does prematurity alter the course of respiratory syncytial virus infection?Crit Care Med 1990; 18: 1357–1359.
Toms GL. Respiratory syncytial virus: virology, diagnosis and vaccination.Lung 1990; 168 (Suppl): 388–395.
Hall CB. Respiratory syncytial virus. In: Mandell GL, Douglas RG, Bennett JE, eds.Principles and practices of infections diseases. 3rd ed. New York. Churchill Livingston, 1990; 1265–1279.
Hall CB, McBride JR. Respiratory syncytial virus-from chimps with colds to conundrums and cures.N Engl J Med 1991; 325: 57–58.
Andreson LJ, Hendry RM, Pierik LT,et al. Multicentre study of strains of respiratory syncytial virus.J Infect Dis 1991; 163: 687–692.
Hall CB, Walsh EE, Long CE,et al. Immunity to and frequency of reinfection with respiratory syncytial virus.J Infect Dis 1991; 163: 693–698.
McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis.Am J Dis Child 1986; 140: 806–812.
Carlsen KH, Larsen S, Bjerve O,et al. Acute bronchiolitis: predisposing factors and characterization of infants at risk.Pediatr Pulmonol 1987; 3: 153–160.
Ogra PL, Patel JP. Respiratory syncytial virus infection and the immunocompromised host.Pediatr Infect Dis J 1988; 7: 246–249.
Pickens DL, Scheffi GL, Storch GA,et al. Characterization of prolonged apneic episodes associated with respiratory syncytial virus infection.Pediatr Plumonol 1989; 6: 195–201.
Halstead DC, Todd S, Fritch G. Evaluation of five methods for respiratory syncytial virus detection.J Clin Microbiol 1990; 28: 1021–1025.
Paton AW, Paton JC, Lawrence AJ,et al. Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by reverse transcription and polymerase chain reaction amplification.J Clin Microbiol 1992; 30: 901–904.
Kellogg JA. Culture vs. direct antigen assays for detection of microbial pathogens from lower respiratory tract specimens suspected of containing the respiratory syncytial virus.Arch Pathol Lab Med 1991; 115: 451–458.
Gozal D, Colin AA, Jaffe M,et al. Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis.Pediatr Res 1990; 27: 204–220.
Van Steensel-Moll HA, Hazelzet JA, Van Der Voort E,et al. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus.Arch Dis Child 1990; 65: 1237–1239.
Schuh S, Parkin P, Rajan A,et al. High versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma.Pediatrics 1989; 83: 513–518.
Wang EE, Milner R, Allen U,et al. Bronchodilators for treatment of mild bronchiolitis: a factorial randomized trial.Arch Dis Child 1992; 67: 289–293.
Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants.Pediatrics 1983; 71: 13–18.
The American Academy of Pediatrics Committee on Infection Disease. Ribavirin therapy of respiratory syncytial virus.Pediatrics 1987; 79: 475–478.
American Academy of Pediatrics Committee on Infectious Diseases. Use of Ribavirin in treatment of respiratory syncytial virus infection.Pediatrics 1993; 92: 501–504.
Wald ER, Dashefsky B, Green M. Ribavirin: A case of premature adjudication?J Pediatr 1988; 112: 154–158.
Zucker AR, Meadwo WL. Pediatric critical care physicians attitude about guidelines for the use of Ribavirin in critically ill children with respiratory syncytial virus pneumonia.Crit Care Med 1995; 23 (4): 767–772.
Smith DW, Frankel LR, Mathers LH,et al. A controlled trial of aerosolized Ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.N Engl J Med 1991; 325: 24–29.
Meert KL, Sarnaik AP, Gelmini MJ,et al. Aerosolized Ribavirin in mechanically ventilated infants with respiratory syncytial virus lower respiratory tract disease.Crit Care Med 1994; 22: 566–572.
Hemming VG, Prince GA, Groothuis JR, Siber GR. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Clin Microbiol Rev 1995; 8 (1): 22–23.
Groothuis JR, Simoes EAR, Levin MJ,et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children.N Engl J Med 1993; 329: 1524–1530.
Groothuis JR, Simoes EAF, Hemming VG. RSV infection in preterm infants and the protective effects of RSV immune globulin (RSVIG).Pediatrics 1995; 95 (4): 463–467.
Hall CB. Prospects for a RSV vaccine.Science 1994; 265 (5177): 1391–1394.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aggarwal, R. Lower airway disease caused by respiratory syncytial virus. Indian J Pediatr 65, 355–362 (1998). https://doi.org/10.1007/BF02761127
Issue Date:
DOI: https://doi.org/10.1007/BF02761127